0001209191-17-043813.txt : 20170705 0001209191-17-043813.hdr.sgml : 20170705 20170705202245 ACCESSION NUMBER: 0001209191-17-043813 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170701 FILED AS OF DATE: 20170705 DATE AS OF CHANGE: 20170705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTIME INC CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHLACHET DAVID CENTRAL INDEX KEY: 0001235445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 17950588 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-01 0 0000876343 BIOTIME INC BTX 0001235445 SCHLACHET DAVID 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 1 0 0 0 Common Shares, no par value 32050 I see footnote Option to Purchase Common Shares 3.15 2017-07-01 4 A 0 20000 0.00 A 2022-06-30 Common Shares 20000 20000 D Option to Purchase Common Shares 2.72 2021-06-30 Common Shares 20000 20000 D Option to Purchase Common Shares 3.57 2020-06-30 Common Shares 20000 20000 D Option to Purchase Common Shares 3.11 2019-06-30 Common Shares 20000 20000 D Option to Purchase Common Shares 2.86 2019-04-10 Common Shares 20000 20000 D All shares are owned by Schlachet Management Ltd., a privately held company of which Mr. Schlachet is the sole shareholder, chief executive officer, and director. Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2017 based upon continued service on the board of directors. Became exercisable in four equal quarterly installments after the date of grant on July 1, 2016. Became exercisable in four equal quarterly installments after the date of grant on July 1, 2015. Became exercisable in four equal quarterly installments after the date of grant on July 1, 2014. Became exercisable in four equal quarterly installments after the date of grant on April 11, 2014. /s/David Schlachet 2017-07-05